Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Lung Cancer News ••• Topics • Countries • U.S. States

Non-Small Cell Lung Cancer (NSCLC) News Monitoring

Get by Email • RSS

Published on May 29, 2025

Cancer drugmaker iTeos to shut down

Dive Brief: Cancer drugmaker iTeos Therapeutics said Wednesday it plans to wind down operations and seek to sell the company’s assets and intellectual property rights. ITeos has for years struggled to develop a cancer treatment that sufficiently impressed …

Source: BioPharma Dive - Pending
Published on May 28, 2025

Phase 1/2 Trial Investigating ATR-04 for EGFRi-Related Rashes in Lung Cancer

The phase 1/2 ATR04-484 clinical trial is examining ATR-04 therapy for the treatment of EGFR inhibitor-associated rashes in patients with non-small cell lung cancer, colorectal cancer and others, according to a news release from Azitra, Inc., a …

Source: Cure Today - Neutral
Published on May 28, 2025

Neoadjuvant Efti/Keytruda Combo Improves Tumor Fibrosis Rates in Sarcoma

Neoadjuvant treatment with eftilagimod alfa (IMP321; efti) and Keytruda (pembrolizumab) plus radiotherapy significantly improved tumor hyalinization/fibrosis rates compared with radiotherapy alone in patients with resectable soft tissue sarcoma, …

Source: Cure Today - Neutral
Published on May 28, 2025

New Biomarker Offers Insight for Optimizing KRAS Inhibitor Therapy in Lung Cancer

In a groundbreaking study published in Nature Medicine, researchers at The University of Texas MD Anderson Cancer Center have uncovered a critical biomarker that dramatically improves the prediction of clinical outcomes in patients with advanced KRAS G12C- …

Source: Bioengineer.org - Pending
Published on May 28, 2025

Lung Cancer Biomarker TTF-1 Guides KRAS-Targeted Therapy

Register for free to listen to this article Thank you. Listen to this article using the player above. ✖ Want to listen to this article for FREE? Complete the form below to unlock access to ALL audio articles. Researchers from The University of Texas MD …

Source: Technology Networks - Neutral
Published on May 28, 2025

Coherus and STORM Therapeutics Partner to Evaluate STC-15 with LOQTORZI in Clinical Trial

Coherus BioSciences, Inc. announced a clinical collaboration with STORM Therapeutics, Ltd. (“STORM”) to evaluate STC-15, a METTL3 inhibitor, in combination with LOQTORZI (toripalimab-tpzi), a next-generation PD-1 inhibitor, in a Phase 1b/2 study for …

Source: Pharma Journalist - Neutral
Published on May 28, 2025

Global CTLA4 Inhibitors Market Forecast: Key Growth Drivers, Trends, and Opportunities from 2025 to 2034

The Business Research Company's CTLA4 Inhibitors Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Latest …

Distribution channels: Business & Economy, Companies ...
Published on May 28, 2025

Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of ...

NEEDHAM, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 28, 2025

New Biomarker May Guide Best Use of KRAS Inhibitors in Lung Cancer

Lung cancer patients with high TTF-1 expression had improved survival outcomes following treatment with the KRAS inhibitor sotorasib This biomarker may help physicians determine those most likely to benefit from sotorasib and those who may need alternative …

Source: Newswise - Neutral
Published on May 28, 2025

Merck shares promising phase 3 results for Keytruda in ovarian cancer

Merck & Co – known as MSD outside the US and Canada – has shared promising results from a late-stage study of its anti-PD-1 therapy Keytruda (pembrolizumab) in ovarian cancer. The phase 3 KEYNOTE-B96 trial has been evaluating the drug in combination …

Source: PMLiVE - Neutral
Published on May 28, 2025

AKTIS ONCOLOGY INITIATES PHASE 1B CLINICAL TRIAL OF ITS NECTIN-4-TARGETING RADIOPHARMACEUTICAL PRODUCT CANDIDATE, AKY-...

US FDA cleared INDs for [225Ac]Ac-AKY-1189 and [64Cu]Cu-AKY-1189 for initiation of broad NECTINIUM-2 Phase 1b trial NECTINIUM-2 will evaluate [225Ac]Ac-AKY-1189 for the treatment of patients with locally advanced or metastatic urothelial carcinoma, triple …

Source: WFMZ - Pennsylvania - Neutral
Published on May 28, 2025

Experimental drug fights lung cancer in nonsmokers: ‘I feel like I did when I was healthy’

Almost two years ago, Mireya Soriano, an Argentine engineer, writer and journalist, completely lost her appetite. Her strength drained away, and she began to feel severe pain in her right side. At La Paz Hospital in Madrid, where she has lived for more …

Source: El País - Center-left
Published on May 28, 2025

Advancements in Nanocarrier Delivery Systems for Photodynamic Therapy in Lung Cancer

Introduction A recent report by the International Agency for Research on Cancer estimated that approximately 19.3 million new cancer cases and 9.9 million cancer-related deaths occurred globally in 2020.1 The report also predicts a 56.4% increase in these …

Source: Dove Medical Press - Neutral
Published on May 28, 2025

Undeterred by Political, Economic Headwinds, Pharma Ups R&D Investment in 2024 and Beyond

Even with strong macro headwinds—inflation, rising costs, geopolitical tensions—the global pharmaceuticals industry continued to pump more money into R&D investments in 2024. That’s according to data from analyst firm Evaluate Pharma, which in an email …

Source: BioSpace - Pending
Published on May 28, 2025

Next-gen Korean cancer fighters to showcase innovation at ASCO 2025

Korean pharmaceutical and biotech companies are set to present major research milestones at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from Friday to Tuesday in Chicago. ASCO, one of the world’s three leading cancer …

Source: Korea Biomedical Review - Neutral
Published on May 27, 2025

Advances in Modern Radiotherapy for Lung Cancer

In the relentless quest to improve outcomes for patients battling locally advanced non-small cell lung cancer (LA-NSCLC), a groundbreaking meta-analysis ushers in fresh hope through innovations in radiotherapy regimens. The recent study rigorously …

Source: Bioengineer.org - Pending
Published on May 27, 2025

First Patient Dosed in MORNINGSTAR Trial of Mavrostobart for Solid Tumors

The first patient has been dosed with mavrostobart (PT199) in combination with chemotherapy in the phase 1/2 MORNINGSTAR clinical trial for those with solid tumors, according to a news release from Phanes Therapeutics, Inc. The study is set to evaluate …

Source: Cure Today - Neutral
Published on May 27, 2025

AbbVie To Present Cancer Trial Data At Upcoming ASCO Event

AbbVie Inc ABBV stock is trending on Tuesday after the U.S. drug giant announced that key data from its broad oncology portfolio will be showcased at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting. An oral presentation on …

Source: Benzinga - Neutral
Published on May 28, 2025

Radiation-Induced Lymphopenia Prognosis and Risk Factors in Postmastectomy Radiotherapy Patients

Introduction Breast cancer, the leading cancer in women and the second most common cancer globally,1 is typically treated through a multidisciplinary comprehensive methodology. Radiation therapy is an essential component of the treatment of breast cancer. …

Source: Dove Medical Press - Neutral

02 days 09:24:19

Featured Releases

Got News to Share? · Submit · See All

Published on May 31, 2025 - 12:04 GMT

Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell ...

Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p<0.0001) Libtayo also demonstrated 80% and 65% reductions in the risk of locoregional and distant recurrence, respectively, compared to …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 31, 2025 - 12:00 GMT

Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated incidence and mortality in a high-risk population Data …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on May 31, 2025 - 12:00 GMT

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/...

Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 31, 2025 - 12:00 GMT

ImPact Biotech Presents Interim Analysis from Phase 3 ENLIGHTED Study of Padeliporfin VTP in LG UTUC at ASCO 2025

– Complete response (CR) observed in 73% (27/37) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed the Induction Treatment Phase (ITP) – – Padeliporfin VTP treatment continues to be safe and well-tolerated, …

Distribution channels: Technology ...

Published on May 27, 2025 - 13:01 GMT

Lung Cancer Therapeutics Market Accelerates Amid Innovation, Policy Support, and R&D Deals | DataM Intelligence

Lung cancer therapeutics market booming with 10.5% CAGR through 2031, fueled by advances in immunotherapy, diagnostics, and global industry partnerships. AUSTIN, TX, UNITED STATES, May 27, 2025 /⁨EINPresswire.com⁩/ -- The global lung cancer …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 12:30 GMT

Novel Drug Delivery System Market to Reach $67.3Bn by 2031, Growing at 21.2% CAGR | DataM Intelligence

Novel Drug Delivery System Market to reach $67.3B by 2031, growing at 21.2% CAGR due to nanotech, biologics, and patient-driven drug delivery solutions. NEW YORK, NY, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Market Overview The Novel …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 11:39 GMT

In-Depth Analysis Of The Global Sarcoidosis Market: Key Drivers, Trends, Growth Opportunities, And Forecast 2025-2034

The Business Research Company’s Sarcoidosis Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /⁨EINPresswire.com⁩/ -- What Is The Forecasted Growth Of The Sarcoidosis …

Distribution channels: Business & Economy, Chemical Industry ...
Published on May 30, 2025 - 20:15 GMT

Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights

Company continues to progress both REYOBIQ™ radiotherapeutic clinical trials and CNSide® CSF assay platform launch readiness HOUSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage …

Distribution channels:

Got news to share? Submit it now.

Load more lung cancer news or search news using your own keywords. There are 817,890,209 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Lung Cancer News by Country

Lung Cancer News by U.S. State

Lung Cancer News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on May 31, 2025 - 15:15 GMT

San Francisco Dental Implant Center Announces New Content on Convenient Dental Implant Locations in SF

San Francisco Dental Implant Center, a top dental implant center in San Francisco, California, is proud to announce new content focusing on convenient location. SAN FRANCISCO, CA, UNITED STATES, May 31, 2025 /⁨EINPresswire.com⁩/ -- San Francisco …

Distribution channels: Building & Construction Industry, Consumer Goods ...
Published on May 31, 2025 - 12:04 GMT

Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell ...

Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p<0.0001) Libtayo also demonstrated 80% and 65% reductions in the risk of locoregional and distant recurrence, respectively, compared to …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 31, 2025 - 12:00 GMT

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/...

Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 31, 2025 - 00:00 GMT

The Good Feet Store Opens in Seabrook, NH to Help Local Residents and Workforce Live the Life They Love

The Leading Retailer of Premium, Personally-Fitted Arch Supports Expands with the Tenth Store in the Boston Area SEABROOK, NH, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- The Good Feet Store, recognized nationally as the market-leading …

Distribution channels: Companies, Consumer Goods ...
Published on May 31, 2025 - 00:00 GMT

Nurses for Natural Health Hosts Transformative Yoga Retreat for Nurses in France

PHOENIX , AZ, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- This July, Nurses for Natural Health invites nurses from around the world to join a one-of-a-kind restorative yoga retreat in the picturesque town of Luz-Saint-Sauveur. Designed to …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on May 31, 2025 - 12:00 GMT

Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in ...

Phase III NAPOLI 3 trial is the largest and has the longest follow-up for an interventional study in metastatic pancreatic adenocarcinoma1 Post-hoc analysis of NAPOLI 3 study determined characteristics associated with long-term survival, with median …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 31, 2025 - 12:00 GMT

Une analyse « Late Breaking » démontre les caractéristiques associées à la survie globale à long terme des patients avec ...

L’essai de Phase III NAPOLI 3 est la plus grande étude interventionnelle réalisée à ce jour avec la plus longue période de suivi des patients avec un adénocarcinome pancréatique métastatique1. L’analyse post-hoc de l’étude NAPOLI 3 a permis de déterminer …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 31, 2025 - 12:00 GMT

Harbinger Health Showcases Multi-Cancer Early Detection Performance in High-Risk Populations at ASCO 2025

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated incidence and mortality in a high-risk population Data …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on May 31, 2025 - 12:00 GMT

Xilio Therapeutics Announces Updated Phase 2 Data for Vilastobart, a Tumor-Activated Anti-CTLA-4, in Combination with ...

26% preliminary objective response rate observed in heavily pre-treated patients with metastatic microsatellite stable colorectal cancer (MSS CRC) without liver metastases Deep and durable responses ongoing for up to 37 weeks through the data cutoff, …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 30, 2025 - 22:30 GMT

From protocol to empathetic accompaniment: improving dialysis care via psychological education

A groundbreaking shift is happening in the treatment of chronic kidney disease thanks to the work of psychologist Mrs. Erika Danitza Rocabado Vargas. RICHMOND, VA, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- With over 19 years of clinical …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 30, 2025 - 21:46 GMT

NYC Optician French Optical Fashion, Inc. Educates on Eye Wellness

French Optical Fashion, Inc. launches NYC optician campaign to promote eye health with exams and education. NEW YORK, NY, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- French Optical Fashion, Inc., a premier NYC optician located at 7 East …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 21:45 GMT

BREAST CANCER ALLIANCE AWARDS $1.3M IN GRANTS TO ADVANCE RESEARCH, BREAST SURGICAL ONCOLOGY TRAINING, AND ACCESS TO CARE

GREENWICH, CT, CT, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Breast Cancer Alliance (BCA), one of the nation’s leading and most impactful nonprofit breast cancer organizations, proudly announces the awarding of $1.3 million in 2025 grants …

Distribution channels: Beauty & Hair Care, Education ...
Published on May 30, 2025 - 21:17 GMT

New Book Reveals the Overlooked Toxins Impacting American Homes

A shocking exposé reveals how everyday home materials harm your family—and the proven steps to detox, protect, and rebuild your health. ORLANDO, FL, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- What if the place you trust the most is …

Distribution channels: Agriculture, Farming & Forestry Industry, Book Publishing Industry ...
Published on May 30, 2025 - 20:39 GMT

Meaningful Life Counseling Pioneers Early Couples Therapy in CT for Lasting Love

Meaningful Life Counseling in CT promotes early couples therapy to strengthen relationships, offering free consultations to help partners thrive. WOODBRIDGE, CT, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- As couples face mounting …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 20:00 GMT

Mobility City Holdings Inc Celebrates Six Years of Serving People in Lake County Illinois & Surrounding Communities

Kevin Pignone opened his showroom in Grayslake IL with a mission to help people with mobility challenges via the repair, rental and sale of mobility equipment BOCA RATON, FL, US, May 30, 2025 /⁨EINPresswire.com⁩/ -- Mobility City Holdings, Inc., …

Distribution channels: Business & Economy, Companies ...
Published on May 30, 2025 - 19:45 GMT

Free Training Event During CPR and AED Awareness Week Aims to Equip More People to Act in Emergencies

Hands-on virtual session June 6 empowers participants with the skills and confidence to respond in cardiac emergencies—no experience required. HOUSTON, TX, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- In an effort to empower more …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 30, 2025 - 19:15 GMT

LosAngelesMedicalMalpracticeLawyers.com Launches to Connect Individuals with Malpractice Lawyers

LOS ANGELES, CA, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- A new website, losangelesmedicalmalpracticelawyers.com, has been launched to assist individuals in the Los Angeles area in finding the best medical malpractice lawyer for their …

Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...
Published on May 30, 2025 - 19:00 GMT

A New Initiative for the Wellness of Children and Communities: A Mental Health Awareness Event with U.S. - Japan Experts

～Heartfulness × Hip-Hop Therapy × Expressive Arts Therapy ～“M.O.F.U.” to Be Held for the First Time in Katsushika, Tokyo TOKYO, CA, JAPAN, May 30, 2025 /⁨EINPresswire.com⁩/ -- On Saturday, June 7, 2025, a mental health awareness event titled“M.O.F …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 30, 2025 - 18:40 GMT

Media Statement By Dr. Gail C. Christopher: America 5 Years After George Floyd’s Murder

Dr. Christopher, leader of the National Collaborative for Health Equity, says racial justice faces headwinds, but accomplishments have not been erased WASHINGTON, DC, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Five years ago, at the …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on May 30, 2025 - 18:28 GMT

Cosmetic Dentistry Experts Drs. John and Jade Moreau of Unforgettable Smiles Talk How Enhanced Smiles Build Confidence

ALEXANDRIA, LA, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Drs. John and Jade Moreau of Unforgettable Smiles is featured in the latest edition of HelloNation, where he shares valuable insight on the role of cosmetic dentistry in improving both …

Distribution channels: Beauty & Hair Care, Business & Economy ...